medazepam has been researched along with Cancer of Liver in 1 studies
Medazepam: A benzodiazepine derivative used in the treatment of anxiety. It has sedative, muscle relaxant, and anticonvulsant properties. One of its metabolites is DIAZEPAM and one of its excretion products is OXAZEPAM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vrzal, R | 1 |
| Kubesova, K | 1 |
| Pavek, P | 1 |
| Dvorak, Z | 1 |
1 other study available for medazepam and Cancer of Liver
| Article | Year |
|---|---|
Benzodiazepines medazepam and midazolam are activators of pregnane X receptor and weak inducers of CYP3A4: investigation in primary cultures of human hepatocytes and hepatocarcinoma cell lines.
Topics: Anti-Anxiety Agents; Carcinoma, Hepatocellular; Cells, Cultured; Cytochrome P-450 CYP1A1; Cytochrome | 2010 |